tavocept Report issue

Small molecule Experimental
AACT ChEMBL MeSH PubChem

Active Ingredient History

NOW
  • Now

Chemistry

  • SMILES: OS(=O)(=O)CCSSCCS(=O)(=O)O
  • InChIKey: BYUKOOOZTSTOOH-UHFFFAOYSA-N
  • Mol. Mass: 282.39
  • ALogP: 0.14
  • ChEMBL Molecules:
    dimesna  
    None  
More Chemistry

Pharmacology

Alternative names

2,2'-dithiodiethanesulfonic acid | 2,2'-dithiodiethanesulfonic acid, ammonium salt | 2,2'-dithiodiethanesulfonic acid, disodium salt | bnp7787 | dimesna | dimesna sodium | disodium 2,2'-dithio-bis-ethane sulfonate | ethanesulfonic acid, 2,2'-dithiobis- | tavocept

Organizations (5)

Research & Development (5)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Marketing (0)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Indications (10)

Approved Indications (0)

Experimental Indications - Clinical Trial Phases 1-4 (10)


 

Anemia (Phase 2)

Breast Diseases (Phase 3)

Breast Neoplasms (Phase 3)

Carcinoma, Non-Small-Cell Lung (Phase 3)

Drug-Related Side Effects and Adverse Reactions (Phase 2)

Head and Neck Neoplasms (Phase 1)

Lung Neoplasms (Phase 2)

Neoplasm Metastasis (Phase 3)

Neutropenia (Phase 2)

Ovarian Neoplasms (Phase 1)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 5
  • # of Trial Organizations: 5

Trials by Phase

Trial Phase Start Date Organizations Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue